🇺🇸 Stem Cells in United States

42 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Febrile Neutropenia — 7 reports (16.67%)
  2. Infection — 5 reports (11.9%)
  3. Neutropenia — 5 reports (11.9%)
  4. Lung Infiltration — 4 reports (9.52%)
  5. Pyrexia — 4 reports (9.52%)
  6. Respiratory Failure — 4 reports (9.52%)
  7. Stem Cell Transplant — 4 reports (9.52%)
  8. Acute Leukaemia — 3 reports (7.14%)
  9. Diarrhoea — 3 reports (7.14%)
  10. Drug Ineffective — 3 reports (7.14%)

Source database →

Stem Cells in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Stem Cells approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Stem Cells in United States?

TC Erciyes University is the originator. The local marketing authorisation holder may differ — check the official source linked above.